Braveheart Bio Inc. (BRVE)
BRVE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$19.33
-5.06% on the day
Market cap
$1.7B
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BRVE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002131524 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document S-1/A | 424B4 | 2026-08-06 |
| Latest quarterly / interim | 10-Q | 2026-09-08 |
| Latest current report | 8-K | 2026-09-08 |
Source: SEC EDGAR submissions feed, 46 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.5% |
| 1 month | -27.3% |
| 3 months | Not enough price history |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -35.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc. Common Stock (DE) | $16.51 | -5.33% | $1.7B |
| XNCR | Xencor Inc. | $23.52 | -6.07% | $1.7B |
| TRVI | Trevi Therapeutics Inc. | $12.29 | -4.95% | $1.8B |
| BHVN | Biohaven Ltd. Common Shares | $11.42 | -3.30% | $1.7B |
| ZYME | Zymeworks Inc. | $25.07 | -1.03% | $1.8B |
| SEPN | Septerna Inc. | $36.41 | -3.05% | $1.7B |
| MRVI | Maravai LifeSciences Holdings Inc. | $6.53 | -7.51% | $1.7B |
| AGIO | Agios Pharmaceuticals Inc. | $30.21 | -1.98% | $1.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier